Biotech

Jon Clardy, 1943-2026

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 09/11/2026, 18:04:29 UTC.

Briefings

Jon Clardy, a prominent chemical biologist and crystallographer, died in 2026 due to acute myeloid leukemia. He spent decades at Cornell and Iowa State before joining Harvard, where he co-founded the Chemical Biology program with Stuart Schreiber and Greg Verdine. His work included solving X-ray structures of complex natural products like bryostatin and saxitoxin, and elucidating the molecular glue mechanism involving FKBP12, rapamycin, and mTOR. He is remembered for his contributions to structural biology and drug discovery.

Key points

• Jon Clardy died in 2026 due to acute myeloid leukemia.
• He spent 80s and 90s at Cornell and Iowa State before joining Harvard.

Context

Clardy's impact spans chemical biology, natural products, and X-ray crystallography. His collaboration with Stuart Schreiber's lab at Harvard established a dedicated program in Chemical Biology that has been influential for the last 25 years.

Limitations

Evidence covers only his death and early career timeline. Specific dates for later Harvard work are not provided. No direct quotes or personal anecdotes are included in the source.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 10/11/2026, 08:04:08 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeifcrfhg2tnrhqi4c7w4ukudtsrpmwoz2yrlupe7u55tlxe2hrnoga